RESPONSE DX MELANOMA

Brand Owner Address Description
RESPONSEDX: MELANOMA CANCER GENETICS, INC. 201 Route 17 N., 2nd Floor Rutherford NJ 07070 RESPONSE DX: MELANOMA;Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information;MELANOMA;Medical research; scientific research and development, medical and scientific research consulting; drug discovery analysis services; pharmaceutical drug development analysis services; diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing scientific research information in the field of pharmaceuticals and clinical trials; providing an on-line computer database for others in the fields of medicine development, pharmacogenomics in the nature of scientific research in the field of genetics, scientific research information in the field of cancer diagnosis, scientific research information in the field of clinical trial design and scientific research information in the field of biotechnology; product development services for others in the biomedical, genomics, pharmacogenomics, diagnostic, clinical trial design and biotechnology fields;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.